Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase
US9169224B2 · kind B2 · utility
2Cited by
12References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 13, 2013 |
| Grant date | Oct 27, 2015 |
| Priority date | — |
| Expiry date | Aug 13, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Certain piperazinyl and piperidinyl urea compounds are useful as FAAH inhibitors. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by fatty acid amide hydrolase (FAAH) activity. Thus, the compounds may be administered to treat, e.g., anxiety, pain, inflammation, sleep disorders, eating disorders, or movement disorders (such as multiple sclerosis).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.